Calidi Biotherapeutics
CLDI
CLDI
28 hedge funds and large institutions have $479K invested in Calidi Biotherapeutics in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less capital invested
Capital invested by funds: $525K → $479K (-$45.9K)
Holders
28
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$660K | |
| 2 | +$327K | |
| 3 | +$188K | |
| 4 |
VF
Virtu Financial
New York
|
+$41K |
| 5 |
AAP
Arax Advisory Partners
Denver,
Colorado
|
+$28.1K |
Top Sellers
| 1 | -$173K | |
| 2 | -$16.3K | |
| 3 | -$8.79K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.03K |
| 5 |
BC
Barrett & Company
Providence,
Rhode Island
|
-$342 |
